MedTrace Logo

CWI and Discharge After Breast Cancer Surgery

NCT02897934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2021-02-02

No results posted yet for this study

Summary

The objectives of this work are threefold:

1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery
2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care
3. To evaluate patient satisfaction with their care pathway

Conditions

Interventions

DRUG

Bupivacaine continuous infusion

The use of continuous wound infusion of bupivacaine

Sponsors & Collaborators

  • University College Cork

    lead OTHER

Principal Investigators

  • Brian O'Donnell, MD · Cork University Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-01-01
Completion
2018-07-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02897934 on ClinicalTrials.gov